Keywords: Tumors (Pre-Treatment), Quantitative Imaging, Tumors (Pre-Treatment), IDH1,APT,synthetic MRI,Glioma
Motivation: Mutations in the IDH1 gene are pivotal in the pathogenesis,classification, and prognostic evaluation of gliomas. Predicting these mutations using non-invasive methods is of substantial clinical importance.
Goal(s): To explore the capability of synthetic MRI combined with Amide Proton Transfer (APT) in predicting the IDH1 gene status in gliomas.
Approach: 51 IDH1-mutant and 34 IDH1-wildtype glioma patients were collected to compare their synthetic MRI and APT quantitative parameters, the diagnostic value of these parameters in predicting IDH1 gene status being assessed.
Results: The quantitative parameters of synthetic MRI and APT are effective in predicting IDH1 mutation status.Their combined application achieves the highest predictive performance.
Impact: The combination of synthetic MRI and APT provides a novel and reliable non-invasive diagnostic method for predicting IDH1 gene status, offering an valuable imaging approach for the development of personalized treatment plans and prognostic assessments in clinical practice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords